Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Email Surveillance Generates Court Battle And Image Problem

This article was originally published in The Tan Sheet

Executive Summary

FDA’s biggest battle could be in the court of public opinion as employees claim the agency targeted and suppressed them based on their viewpoints and conducted intrusive searches and seizures. FDA says the surveillance began after a device industry attorney complained that a firm’s confidential information had been released.

You may also be interested in...



Grassley Probes FDA Contractor’s Posting Of Confidential Documents

The ranking member of the Judiciary Committee said “thousands of pages of NIH grant information, including internal emails and documents, were easily accessible online” through Quality Associates’ site.” He also asked why internal documents were available publicly and searchable on search engines.

Grassley Probes FDA Contractor’s Posting Of Confidential Documents

The ranking member of the Judiciary Committee said “thousands of pages of NIH grant information, including internal emails and documents, were easily accessible online” through Quality Associates’ site.” He also asked why internal documents were available publicly and searchable on search engines.

FDA Spyware Suit: Whistleblowers Challenge Agency Over Email Surveillance

Six current and former employees of FDA’s device center file suit in the U.S. District Court in Washington, D.C., arguing that email and computer surveillance violated their constitutional and legal whistleblower rights.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS105888

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel